Archive for the ‘biotech/medical’ category: Page 2495
Dec 25, 2016
We’ll have an Alzheimer’s drug by 2025, experts say
Posted by Dan Kummer in categories: biotech/medical, neuroscience
But experts across the field say hope is not lost. They believe we will have some form of drug against the disease by 2025, albeit most likely a pilot version that will need to be upgraded.
Dec 25, 2016
Scientists develop a cancer-detecting smartphone add-on that’s up to 99% accurate
Posted by Shane Hinshaw in categories: biotech/medical, mobile phones
A new smartphone add-on has been demonstrated to detect cancer with 99% accuracy in the lab. The breakthrough could have significant implications for diagnostic capabilities in remote areas or when limited medical services are available.
Dec 25, 2016
Now You Can Make Movies of Living Cells With Your Smartphone!
Posted by Karen Hurst in categories: 3D printing, biotech/medical, mobile phones
Very cool; I do look forward to see where we land in the next 5 years on mobile imaging systems.
Years ago I remember developing software for a mobile blood gas analyzer to help researchers and doctors in some of the world’s most remote locations. And, the technology then did improve survival rates for so many. And, I see advances like this one doing so much for many who do not have access or the luxury of centralize labs, or hospitals, etc.
Continue reading “Now You Can Make Movies of Living Cells With Your Smartphone!” »
Dec 24, 2016
Overpopulation – The Human Explosion Explained
Posted by Steve Hill in categories: biotech/medical, life extension
We should not let concerns about overpopulation hold us back from developing biotechnology to treat age-related diseases. Compassion is the reason that trumps any other argument against developing this technology.
Dec 24, 2016
CellAge Campaign Q&A: Is It Safe To Remove Senescent Cells? | Lifespan.io
Posted by Steve Hill in categories: biotech/medical, health, life extension
Is it safe to remove senescent cells? This is a common question we hear when talking about senolytic therapies designed to remove these problem cells that accumulate with age and play havoc with the body and its ability to repair.
Mantas from CellAge answers a question from one of our readers about senescent cell removal therapy. The removal of senescent cells has become a very hot topic this year with numerous experiments showing positive results for health and disease mitigation.
Continue reading “CellAge Campaign Q&A: Is It Safe To Remove Senescent Cells? | Lifespan.io” »
Dec 24, 2016
Nanotechnology in Healthcare: Getting Smaller and Smarter
Posted by Klaus Baldauf in categories: biotech/medical, nanotechnology
https://youtube.com/watch?v=1ACoUCm8aTA
I believe nanodevices will operate as drug delivery systems, cancer treatment tools or tiny surgeons. Let me introduce you nanotechnology in healthcare.
Dec 23, 2016
What humans will look like in 100 years’ time
Posted by Klaus Baldauf in categories: biotech/medical, existential risks, genetics
What humans will look like in 100 years: Expert reveals the genetically modified bodies we’ll need to survive
- Harvard researchers says to survive the next extinction we must leave the Earth
- But to live on other planets we will need to genetically modify our organs
- Experts have previously speculated how humanity will look in 1,000 years’ time
- Video describes scenario in which bodies are part-human part-machine
By Harry Pettit For Mailonline
Continue reading “What humans will look like in 100 years’ time” »
Dec 23, 2016
Scientists identify unique “breathprint” of 17 diseases
Posted by Shane Hinshaw in category: biotech/medical
Could a nano array that can identify the chemical signatures of diseases bring us closer to the day when doctors might be able to use a medical tricorder a la Star Trek to instantly diagnose a patient’s conditions?
Dec 23, 2016
Positive multiple sclerosis clinical trial suggests ‘unprecedented’ effects in relapsing form of the disease
Posted by Steve Hill in category: biotech/medical
More progress in treating MS.
In findings that show the effectiveness of a new strategy for treating multiple sclerosis (MS), researchers are reporting positive results from three large, international, multicenter Phase III clinical trials of the investigational drug ocrelizumab (brand name Ocrevus) in both relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS).
The trial results are published online on Dec. 21, 2016, in The New England Journal of Medicine (NEJM), and are discussed in an accompanying editorial.